alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › combating

combating

2 studies tagged combating, dated 2015-05-11 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review 2024-01-01
  2. Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein 2015-05-11

Studies

2 studies carry this tag.

Date range

2015 to 2024

Top journals

  • Current topics in medicinal chemistry 1
  • Neurologia 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Current topics in medicinal chemistry 2024-01-01 Drug development

    With a focus on AD, the molecular and pharmacological effects of a few GLP-1/GIP analogs, both synthetic and natural, as well as DPP4 inhibitors, have been mentioned, which are in the preclinical and clinical studies.

  2. Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neurologia 2015-05-11 Treatments

    The amyloidogenic hypothesis proposes that β-amyloid plays a key role in AD.

All topic tags with their study counts